Robert De Jager

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer

Journal of Clinical Oncology · 2006 · 236 citations

DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies

Journal of Clinical Oncology · 2000 · Last of 13 authors · 41 citations